SNES official logo SNES
SNES 3-star rating from Upturn Advisory
SenesTech Inc (SNES) company logo

SenesTech Inc (SNES)

SenesTech Inc (SNES) 3-star rating from Upturn Advisory
$2.97
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/05/2025: SNES (3-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 3 star rating for performance

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $10

1 Year Target Price $10

Analysts Price Target For last 52 week
$10 Target price
52w Low $1.3
Current$2.97
52w High $6.24

Analysis of Past Performance

Type Stock
Historic Profit 51.59%
Avg. Invested days 58
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/05/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 15.51M USD
Price to earnings Ratio -
1Y Target Price 10
Price to earnings Ratio -
1Y Target Price 10
Volume (30-day avg) 1
Beta 0.21
52 Weeks Range 1.30 - 6.24
Updated Date 12/6/2025
52 Weeks Range 1.30 - 6.24
Updated Date 12/6/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.21

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Earnings Date

Report Date 2025-11-11
When After Market
Estimate -0.35
Actual -0.28

Profitability

Profit Margin -253.54%
Operating Margin (TTM) -195.22%

Management Effectiveness

Return on Assets (TTM) -38.54%
Return on Equity (TTM) -77.79%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 7477283
Price to Sales(TTM) 6.74
Enterprise Value 7477283
Price to Sales(TTM) 6.74
Enterprise Value to Revenue 3.25
Enterprise Value to EBITDA 0.11
Shares Outstanding 5223015
Shares Floating 4510648
Shares Outstanding 5223015
Shares Floating 4510648
Percent Insiders 4.21
Percent Institutions 10.62

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

SenesTech Inc

SenesTech Inc(SNES) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

SenesTech Inc. was founded in 2013 with a focus on developing and commercializing innovative solutions to combat the effects of cellular senescence. Its flagship product, ContraPestu00ae, targets the underlying biology of aging cells and has undergone extensive research and development, including successful clinical trials for both male and female pest populations. The company has evolved to establish a growing commercial presence, aiming to disrupt traditional pest control methods with its novel approach.

Company business area logo Core Business Areas

  • Product Development and Commercialization: SenesTech's primary business involves the research, development, manufacturing, and commercialization of its proprietary non-lethal, biodegradable pest control products, primarily targeting the rodent population.
  • Intellectual Property and Licensing: The company's core intellectual property portfolio protects its technology. Future growth may involve licensing opportunities or partnerships.

leadership logo Leadership and Structure

SenesTech Inc. is led by a management team with expertise in biotechnology, pest management, and business development. Specific details on the current leadership team and organizational structure would typically be found in their investor relations materials or annual reports.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • ContraPestu00ae: ContraPestu00ae is a proprietary, non-lethal, biodegradable pest control product designed to reduce fertility in rodent populations. It is administered orally and works by inducing temporary infertility in both male and female rodents, thereby reducing breeding and population size over time. Market share data for ContraPestu00ae is nascent as it is an emerging product in a historically established market. Key competitors include traditional rodenticide manufacturers and integrated pest management (IPM) service providers. Revenue figures and specific market share percentages are not readily available publicly at this stage of commercialization but are expected to grow as adoption increases.

Market Dynamics

industry overview logo Industry Overview

SenesTech operates within the global pest control market, a substantial and established industry driven by concerns over public health, food safety, property damage, and disease transmission. The market is currently dominated by conventional chemical pesticides and established pest management services. There is a growing demand for more sustainable, environmentally friendly, and targeted pest control solutions, creating an opportunity for innovative products like ContraPestu00ae.

Positioning

SenesTech is positioning itself as a pioneer in the emerging field of senolytic pest control. Its competitive advantage lies in its unique, non-lethal, fertility-control approach, which offers a potential alternative to lethal methods. This differentiation can appeal to customers seeking more humane and ecologically sound pest management strategies.

Total Addressable Market (TAM)

The global pest control market is estimated to be worth tens of billions of dollars annually. SenesTech's TAM is primarily within the rodent control segment of this market, which is a significant portion of the overall market. The company's positioning is to capture a share of this market by offering a novel solution that addresses unmet needs for sustainable pest management.

Upturn SWOT Analysis

Strengths

  • Proprietary, non-lethal, fertility-control technology (ContraPestu00ae).
  • Biodegradable and environmentally friendly product profile.
  • Potential for reduced resistance development compared to traditional pesticides.
  • Strong intellectual property portfolio.
  • Addresses growing demand for sustainable pest management.

Weaknesses

  • Emerging product with limited commercial history and brand recognition.
  • Requires education of the market on its novel mechanism of action.
  • Dependence on a single core product for revenue.
  • Manufacturing scalability and cost-effectiveness of production.
  • Limited financial resources compared to established competitors.

Opportunities

  • Expansion into new geographic markets.
  • Development of new applications for its senolytic technology.
  • Partnerships and licensing agreements with larger pest control companies.
  • Increasing regulatory pressure for more environmentally friendly pest control.
  • Growing consumer and institutional demand for sustainable solutions.

Threats

  • Competition from established, well-funded pest control companies.
  • Slow adoption rates by traditional pest management professionals.
  • Potential for new, competing technologies to emerge.
  • Regulatory hurdles or changes in pest control regulations.
  • Unforeseen efficacy or safety concerns with long-term use.

Competitors and Market Share

Key competitor logo Key Competitors

  • Rollins Inc. (ROL)
  • Rentokil Initial plc (RTO)
  • Terminix Global Holdings Inc. (now part of Republic Services - RSG)
  • Ecolab Inc. (ECL)

Competitive Landscape

SenesTech's primary disadvantage against its key competitors is its size, established customer base, and brand recognition. Its advantage lies in its unique, non-lethal, and environmentally friendly approach to rodent control, which differentiates it significantly from the chemical-heavy offerings of many traditional players.

Growth Trajectory and Initiatives

Historical Growth: SenesTech's historical growth has been characterized by the progression from initial research and development to product commercialization and market entry. Growth has been driven by regulatory approvals, the launch of ContraPestu00ae, and initial sales efforts.

Future Projections: Future growth projections for SenesTech are likely dependent on increasing market adoption of ContraPestu00ae, expansion into new customer segments (e.g., municipal, agricultural), and potential development of new product lines. Analyst estimates would provide quantitative projections, but these are not publicly available in this format.

Recent Initiatives: Recent initiatives likely focus on scaling manufacturing, expanding sales and marketing efforts, securing new distribution channels, and further research to validate and expand the applications of its technology.

Summary

SenesTech Inc. is a promising early-stage company with a novel, sustainable approach to pest control through its fertility-modulating product, ContraPestu00ae. Its strengths lie in its proprietary technology and alignment with growing environmental concerns. However, it faces significant challenges in market penetration against established giants and requires substantial investment for scaling and wider adoption. Careful execution of its commercialization strategy and continued innovation will be crucial for its success.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company investor relations websites
  • SEC filings (10-K, 10-Q)
  • Industry research reports
  • Financial news and analysis platforms

Disclaimers:

This JSON output is for informational purposes only and does not constitute financial advice. Market share data and financial performance figures are estimates and subject to change. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About SenesTech Inc

Exchange NASDAQ
Headquaters Phoenix, AZ, United States
IPO Launch date 2016-12-08
CEO, President & Director Mr. Joel L. Fruendt
Sector Basic Materials
Industry Specialty Chemicals
Full time employees 23
Full time employees 23

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption. The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.